157
Views
2
CrossRef citations to date
0
Altmetric
Estimands and Missing Data

Model Averaging Using Likelihoods That Reflect Poor Outcomes for Clinical Trial Dropouts

, &
Pages 79-89 | Received 02 May 2019, Accepted 21 Nov 2019, Published online: 14 Jan 2020

References

  • Ayele, B. T., Lipkovich, I., Molenberghs, G., and Mallinckrodt, C. H. (2014), “A multiple-imputation-based Approach to Sensitivity Analyses and Effectiveness Assessments in Longitudinal Clinical Trials,” Journal of Biopharmaceutical Statistics, 24, 211–228. DOI: 10.1080/10543406.2013.859148.
  • Buckland, S. T., Burnham, K. P., and Augustin, N. H. (1997), “Model Selection: An Integral Part of Inference,” Biometrics, 53, 603–618. DOI: 10.2307/2533961.
  • Carpenter, J. R., Roger, J. H., and Kenward, M. G. (2013), “Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” Journal of Biopharmaceutical Statistics, 23, 1352–1371. DOI: 10.1080/10543406.2013.834911.
  • EMA (2010), “Guideline on Missing Data in Confirmatory Clinical Trials,” Adopted version, September 20, 2010. CPMP/EWP/1776/99 Rev. 1.
  • EMA (2017), “ICH E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” Step 2b, August 30, 2017. EMA/CHMP/ICH/436221/2017.
  • FDA (2002), Antiretroviral Drugs Using Plasma HIV RNA Measurements – Clinical Considerations for Acceleratedand Traditional Approval, l. CDER, FDA, Rockville, MD.
  • Feller, A., Greif, E., Miratrix, L., and Pillai, N. (2016). “Principal Stratification in the Twilight Zone: Weakly Separated Components in Finite Mixture Models.” Available at https://arxiv.org/pdf/1602.06595.pdf.
  • Gaskins, J. T., Daniels, M. J., and Marcus, B. H. (2016), “Bayesian Methods for Nonignorable Dropout in Joint Models in Smoking Cessation Studies,” Journal of the American Statistical Association, 111, 1454–1465. DOI: 10.1080/01621459.2016.1167693.
  • Hogan, J. W., Roy, J., and Korkontzelou, C. (2004), “Tutorial in Biostatistics. Handling Drop-out in Longitudinal Studies,” Statistics in Medicine, 23, 1455–1497. DOI: 10.1002/sim.1728.
  • Hosmer, D. W. (1973), “A Comparison of Iterative Maximum Likelihood Estimates of the Parameters of a Mixture of Two Normal Distributions Under Three Different Types of Sample,” Biometrics, 29, 761–770. DOI: 10.2307/2529141.
  • Kamps, U. (1995), “A concept of generalized order statistics,” Journal of Statistical Planning and Inference, 48, 1–23. DOI: 10.1016/0378-3758(94)00147-N.
  • Lavange, L. M., and Permutt, T. (2016), “A Regulatory Perspective on Missing Data in the Aftermath of the NRC Report,” Statistics in Medicine, 35, 2853–2864. DOI: 10.1002/sim.6840.
  • Leuchs, A-K., Brandt, A., Zinserling, J., and Benda, N. (2017), “Disentangling Estimands and the Intention-to-Treat Principle,” Pharmaceutical Statistics, 16, 12–19. DOI: 10.1002/pst.1791.
  • Liu, G. F., and Pang, L. (2016), “On Analysis of Longitudinal Clinical Trials with Missing Data Using Reference-Based Imputation,” Journal of Biopharmaceutical Statistics, 26, 924–936. DOI: 10.1080/10543406.2015.1094810.
  • Lu, K. (2014), “An Extension of the Placebo-Based Pattern-Mixture Model,” Pharmaceutical Statistics, 13, 103–109. DOI: 10.1002/pst.1605.
  • Mallinckrodt, C. H., Lane, P. W., Schnell, D., Peng, Y., and Mancuso, J. P. (2008), “Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials,” Drug Information Journal, 42, 303–319. DOI: 10.1177/009286150804200402.
  • Mallinckrodt, C., Molenberghs, G., and Rathmann, S. (2017), “Choosing Estimands in Clinical Trials With Missing Data,” Pharmaceutical Statistics, 16, 29–36. DOI: 10.1002/pst.1765.
  • Mallinckrodt, C., Roger, J., Chuang-Stein, C., Molenberghs, G., Lane, P. W., O’kelly, M., Ratitch, B., Xu, L., Gilbert, S., Mehrotra, D. V., Wolfinger, R., and Thijs, H. (2013), “Missing Data: Turning Guidance Into Action,” Statistics in Biopharmaceutical Research, 5, 369–382. DOI: 10.1080/19466315.2013.848822.
  • Mehrotra, D. V., Liu, F., and Permutt, T. (2017), “Missing Data in Clinical Trials: Control-Based Mean Imputation and Sensitivity Analyses,” Pharmaceutical Statistics, 16, 378–392. DOI: 10.1002/pst.1817.
  • Moore, C. M., MaWhinney, S., Forster, J. E., Carlson, N. E., Allshouse, A., Wang, X., Routy, J. P., Conway, B., and Connick, E. (2017), “Accounting for Dropout Reason in Longitudinal Studies With Nonignorable Dropout,” Statistical Methods in Medical Research, 26, 1854–1866. DOI: 10.1177/0962280215590432.
  • NRC (2010), The Prevention and Treatment of Missing Data in Clinical Trials. Panel on Handling Missing Data in Clinical Trials. Committee on National Statistics, Division of Behavioral and Social Sciences and Education, Washington, DC: The National Academics Press.
  • Permutt, T. (2016), “A Taxonomy of Estimands for Regulatory Clinical Trials with Discontinuations,” Statistics in Medicine, 35, 2865–2875. DOI: 10.1002/sim.6841.
  • Permutt, T., and Li, F. (2017), “Trimmed Means for Symptom Trials with dropouts,” Pharmaceutical Statistics, 16, 20–28. DOI: 10.1002/pst.1768.
  • Phillips, A., Abellan-Andres, J., Soren, A., Bretz, F., Fletcher, C., France, L., Garrett, A., Harris, R., Kjaer, M., Keene, O., Morgan, D., Kelly, M. O., and Roger, J. (2017), “Estimands: Discussion Points from the PSI Estimands and Sensitivity Expert Group,” Pharmaceutical Statistics, 16, 6–11. DOI: 10.1002/pst.1745.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.